Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126067931 | 12606793 | 1 | I | 2015 | 20160715 | 20160729 | 20160729 | EXP | US-WEST-WARD PHARMACEUTICALS CORP.-US-H14001-16-01341 | WESTWARD | 0.00 | M | Y | 78.93000 | KG | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126067931 | 12606793 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Unknown | 65410 | |||||||||||
| 126067931 | 12606793 | 2 | C | RAPAMUNE | SIROLIMUS | 1 | Unknown | 0 | 3 | MG | |||||||||
| 126067931 | 12606793 | 3 | C | RAPAMUNE | SIROLIMUS | 1 | Unknown | 0 | 1 | MG | TID | ||||||||
| 126067931 | 12606793 | 4 | C | CYCLOSPORINE. | CYCLOSPORINE | 1 | Unknown | 0 | |||||||||||
| 126067931 | 12606793 | 5 | C | TYLENOL WITH CODEINE | ACETAMINOPHENCODEINE PHOSPHATE | 1 | Unknown | 0 | 1 | DF | |||||||||
| 126067931 | 12606793 | 6 | C | BUMETANIDE. | BUMETANIDE | 1 | Unknown | 0 | QD | ||||||||||
| 126067931 | 12606793 | 7 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | Unknown | 0 | 10 | MG | |||||||||
| 126067931 | 12606793 | 8 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 0 | 5 | MG | QD | ||||||||
| 126067931 | 12606793 | 9 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | 81 | MG | QD | ||||||||
| 126067931 | 12606793 | 10 | C | GABAPENTIN. | GABAPENTIN | 1 | Unknown | 0 | 300 | MG | BID | ||||||||
| 126067931 | 12606793 | 11 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | 2 | DF | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126067931 | 12606793 | 1 | Prophylaxis |
| 126067931 | 12606793 | 2 | Prophylaxis against transplant rejection |
| 126067931 | 12606793 | 4 | Prophylaxis against transplant rejection |
| 126067931 | 12606793 | 5 | Pain |
| 126067931 | 12606793 | 6 | Fluid retention |
| 126067931 | 12606793 | 7 | Sleep disorder |
| 126067931 | 12606793 | 8 | Blood pressure abnormal |
| 126067931 | 12606793 | 9 | Thrombosis prophylaxis |
| 126067931 | 12606793 | 10 | Pain |
| 126067931 | 12606793 | 11 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126067931 | 12606793 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126067931 | 12606793 | Cardiomyopathy | |
| 126067931 | 12606793 | Condition aggravated |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126067931 | 12606793 | 1 | 201503 | 201506 | 0 | |
| 126067931 | 12606793 | 2 | 201503 | 0 | ||
| 126067931 | 12606793 | 3 | 201506 | 0 | ||
| 126067931 | 12606793 | 4 | 20020504 | 0 |